Companies that own MaxCyte Inc.
Legal & General Investment Management Ltd.
3,500,000
9.89%
0
0.01%
07/31/2018
Unicorn Asset Management Ltd.
2,142,857
6.05%
0
0.47%
08/31/2018
Hargreave Hale Ltd.
1,817,253
5.13%
3
0.06%
03/29/2018
BlackRock Investment Management (UK) Ltd.
1,792,857
5.05%
0
0%
06/30/2018
Jupiter Asset Management Ltd.
325,000
0.92%
0
0%
02/28/2018
Octopus Investments Ltd.
125,879
0.36%
125,879
0.02%
05/31/2017
| Address |
22 Firstfield Road
Gaithersburg Maryland 20878
United States
|
|
Employees
|
- |
| Website |
http://www.maxcyte.com |
| Updated |
07/08/2019 |
| MaxCyte, Inc. enages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include MaxCyte STX, MaxCyte VLX, and MaxCyte GT. |
